Cas:41037-26-7 6-Methoxylepidine manufacturer & supplier

Chemical Name:6-Methoxylepidine

CAS.NO:41037-26-7

Synonyms:6-Methoxylepidine;MFCD00191547;6-Methoxy-4-methylpuinoline;Quinoline, 6-methoxy-4-methyl-;6-Methoxy-4-methylquinoline;6-Methoxy-4-Methylquinoline Hydrate;6-methoxyepidine;4-Methyl-6-methoxyquinoline;6-methoxy-4-methyl-quinoline;6-Methoxy-4-methyl-chinolin

Molecular Formula:C₁₁H₁₁NO

Molecular Weight:173.211

HS Code:2933499090

Physical and Chemical Properties:

Melting point:53°C

Boiling point:301.3±22.0 °C at 760 mmHg

Density:1.1±0.1 g/cm3

Index of Refraction:1.599

PSA:22.12000

Exact Mass:173.084061

LogP:2.63

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like 6-Methoxylepidine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Methoxy-4-methyl-chinolin physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Methoxy-4-methyl-chinolin Use and application,Quinoline, 6-methoxy-4-methyl- technical grade,usp/ep/jp grade.

Related News: Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California. 6-Methoxylepidine manufacturer On Friday, the US Association of Flight Attendants — which represents 50,000 flight attendants across 20 airlines — called on the government to work with airlines to discontinue all travel to China until the spread of coronavirus is contained. 6-Methoxylepidine supplier However, the study did not produce any significant benefits when it came to thinking, reasoning and memory tests performed across the entire patient group — possibly because there were too few people with clinically diagnosed Alzheimer’s participating in the trial. 6-Methoxylepidine vendor This decision has shaken the foundations of the scientific process and methods, said Dr. Jason Karlawish, co-director of the Penn Memory Center in Philadelphia. Karlawish ran one of the trial sites for the Biogen drug. 6-Methoxylepidine factory Beta Bionics is pursuing regulatory approval of its insulin-only bionic pancreas, followed by its dual-hormone system, which will also administer a glucagon analog in order to raise blood-sugar levels without the need to consume carbohydrates. Beta Bionics operates in Massachusetts and California.